You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

targeted therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Screening For BCRL In Targeted Therapy For Breast Cancer

Recruiting
  • Lymphedema
  • +10 more
  • Perometer
  • SOZO device
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 21, 2022

Hepatocellular Carcinoma Trial in Changsha (HIPEC+tislelizumab + targeted therapy)

Active, not recruiting
  • Hepatocellular Carcinoma
  • HIPEC+tislelizumab + targeted therapy
  • Changsha, Hunan, China
    Hunan Provincial People's Hospital(The First Affiliated Hospital
Sep 19, 2022

Determining Individualized Cancer Therapy in Pancreatic Cancer

Not yet recruiting
  • Pancreatic Neoplasms
  • Targeted Therapy
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Jun 14, 2023

Metastatic Breast Cancer Trial in Shanghai (Trastuzumab, pyrotinib, Dalpiciclib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Oct 11, 2022

Allergic Contact Dermatitis Trial (Anakinra, Sodium Chloride 9mg/ml Injection)

Not yet recruiting
  • Allergic Contact Dermatitis
  • (no location specified)
Aug 9, 2022

REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy

Not yet recruiting
  • CLL, Relapsed
  • +3 more
    • Clermont-Ferrand, France
    • +7 more
    Nov 16, 2022

    Non Small Cell Lung Cancer Trial (Osimertinib Mesylate)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Osimertinib Mesylate
    • (no location specified)
    May 18, 2022

    Renal Cell Carcinoma Trial (Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 11, 2023

    TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone

    Completed
    • Hepatocellular Carcinoma
    • TACE-HAIC
    • +3 more
    • GuangZhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 8, 2022

    Immunotherapy Among BRAF-Positive Melanoma Patients Treated in

    Completed
    • Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis Investigative Site
    Nov 11, 2022

    Leukemia,Myeloid, Chronic Trial in France (Blood and bone marrow sample)

    Not yet recruiting
    • Leukemia,Myeloid, Chronic
    • Blood and bone marrow sample
    • Annecy, France
    • +15 more
    Nov 10, 2023

    Molecular Imaging in HER2-positive Breast Cancer During

    Enrolling by invitation
    • HER2-positive Breast Cancer
    • Female
    • Tomsk, Russian Federation
    • +1 more
    Jun 7, 2022

    Targeted Therapy to Increase RAI Uptake in Metastatic PTC

    Recruiting
    • Papillary Thyroid Cancer
    • Pediatric Cancer
    • Whole body scan
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Mar 11, 2022

    Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

    Recruiting
    • Relapse/Refractory Multiple Myeloma
    • DeepTag-GPRC5D Targeted CAR T-cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Oct 10, 2023

    Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

    Recruiting
    • Castration-Resistant Prostatic Cancer
    • +4 more
    • Orange City, Florida
    • +1 more
    Nov 23, 2022

    NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Hepatocellular Carcinoma, Transcatheter Arterial ChEmoembolization, Regorafenib Trial in Guangzhou (TACE, Regorafenib)

    Recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Guangzhou, Guangdong, China
      FirstSunYetSen
    Apr 12, 2023

    Cholangiocarcinoma Trial in Tianjin (GEMOX Regimen, Lenvatinib, Toripalimab)

    Recruiting
    • Cholangiocarcinoma
    • GEMOX Regimen
    • +2 more
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute & Hospital
    Jan 28, 2022

    Breast Cancer Trial in Ottawa (Trastuzumab)

    Recruiting
    • Breast Cancer
    • Ottawa, Ontario, Canada
      The Ottawa Hospital Cancer Centre
    Apr 26, 2022

    Nightmares, REM-Sleep Type, PTSD Trial in Geneva (Imagery Rehearsal Therapy and Targeted memory reactivation during REM sleep,

    Recruiting
    • Nightmares, REM-Sleep Type
    • PTSD
    • Imagery Rehearsal Therapy and Targeted memory reactivation during REM sleep
    • Imagery Rehearsal Therapy
    • Geneva, Switzerland
      Center for Sleep Medicine
    Jul 7, 2023

    Chordoma, Chemo Effect Trial in Beijing (camrelizumab and apatinib)

    Recruiting
    • Chordoma
    • Chemotherapy Effect
    • camrelizumab and apatinib
    • Beijing, Beijing, China
      BEIJING
    Nov 14, 2023

    Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients

    Recruiting
    • Melanoma (Skin)
    • +2 more
      • Evora, Portugal
        Hospital Evora
      May 30, 2022

      Clinical Resistance to Targeted Therapy Among Breast Cancer

      Active, not recruiting
      • Breast Cancer
      • Blood draw
      • +3 more
      • Basking Ridge, New Jersey
      • +6 more
      Dec 22, 2022

      Prospective Research for Elderly Early Breast Cancer Patients

      Recruiting
      • Breast Cancer Female
      • Beijing, China
        Peking Union Medical College Hospital
      Dec 26, 2022

      Adenocarcinoma of the Stomach Trial in Goyang (Anti-EGFR antibody in combination with weekly paclitaxel)

      Recruiting
      • Adenocarcinoma of the Stomach
      • Anti-EGFR antibody in combination with weekly paclitaxel
      • Goyang, Gyeonggi, Korea, Republic of
        National Cancer Center
      Nov 29, 2022